Diagnostic
List of headings :
The SarcomaFusion is a molecular diagnostic assay designed to prepare sequencing libraries for the detection of fusion transcripts associated with sarcomas. The test uses a ligation-dependent RT-PCR approach based on specific oligonucleotide probe pairs and includes an internal GAPDH control.
By studying 210 genes, SarcomaFusion enables the detection of fusion transcripts associated with more than 80 types of bone and soft tissue tumours...
 |
The SarcomaFusion is a molecular diagnostic assay designed to prepare sequencing libraries for the detection of fusion transcripts associated with sarcomas. The test uses a ligation-dependent RT-PCR approach based on specific oligonucleotide probe pairs and includes an internal GAPDH control.
By studying 210 genes, SarcomaFusion enables the detection of fusion transcripts associated with more than 80 types of bone and soft tissue tumours...
|
The SarcomaFusion is a molecular diagnostic assay designed to prepare sequencing libraries for the detection of fusion transcripts associated with sarcomas. The test uses a ligation-dependent RT-PCR approach based on specific oligonucleotide probe pairs and includes an internal GAPDH control.
By studying 210 genes, SarcomaFusion enables the detection of fusion transcripts associated with more than 80 types of bone and soft tissue tumours...
|
The SarcomaFusion is a molecular diagnostic assay designed to prepare sequencing libraries for the detection of fusion transcripts associated with sarcomas. The test uses a ligation-dependent RT-PCR approach based on specific oligonucleotide probe pairs and includes an internal GAPDH control.
By studying 210 genes, SarcomaFusion enables the detection of fusion transcripts associated with more than 80 types of bone and soft tissue tumours...
|
The LymphoSign Kit, plays a crucial role in establishing accurate diagnoses and treatment plans for non-Hodgkin’s lymphoma. Leveraging RNA expression levels from over 130 relevant gene markers, this state-of-the-art method provides valuable insights into disease progression. Its simple, fast protocol and suitability for challenging samples make it a powerful tool in non-Hodgkin’s lymphoma research and patient care .
|
The SarcomaFusion test detects fusion transcripts in sarcomas. These transcripts, associated with specific subtypes and targeted treatments, are crucial for patient care. Using patented ligation-dependent PCR technology, the test simplifies diagnostics and enhances our understanding of sarcoma biology. Its rapid protocol and robustness make it a valuable tool in oncology.
|
- 1 patient - 1 tumor - 1 Oncogramme® - 1 treatment -
|
CE/IVD mouse monoclonal antibody
|